Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1946 2
1947 1
1948 1
1953 1
1955 1
1957 2
1961 2
1962 2
1963 4
1964 2
1966 2
1967 1
1968 2
1969 2
1970 2
1971 2
1973 1
1974 1
1975 1
1976 2
1977 1
1979 2
1985 2
1986 3
1989 2
1994 2
1996 1
1997 2
1999 1
2000 3
2001 3
2002 2
2003 3
2004 2
2005 1
2006 6
2007 4
2008 5
2009 10
2010 8
2011 11
2012 8
2013 17
2014 21
2015 10
2016 8
2017 1
2018 3
2019 3
2020 1
2021 1
2022 7
2023 7
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
POISE Study Group; Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. POISE Study Group, et al. Lancet. 2008 May 31;371(9627):1839-47. doi: 10.1016/S0140-6736(08)60601-7. Epub 2008 May 12. Lancet. 2008. PMID: 18479744 Free article. Clinical Trial.
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.
Mackensen A, Haanen JBAG, Koenecke C, Alsdorf W, Wagner-Drouet E, Borchmann P, Heudobler D, Ferstl B, Klobuch S, Bokemeyer C, Desuki A, Lüke F, Kutsch N, Müller F, Smit E, Hillemanns P, Karagiannis P, Wiegert E, He Y, Ho T, Kang-Fortner Q, Schlitter AM, Schulz-Eying C, Finlayson A, Flemmig C, Kühlcke K, Preußner L, Rengstl B, Türeci Ö, Şahin U. Mackensen A, et al. Among authors: finlayson a. Nat Med. 2023 Nov;29(11):2844-2853. doi: 10.1038/s41591-023-02612-0. Epub 2023 Oct 23. Nat Med. 2023. PMID: 37872225 Free PMC article. Clinical Trial.
A Proposed Approach to Allegations of Sexual Boundary Violation in Health Care.
Cooper WO, Foster JJ, Hickson GB, Finlayson AJR, Rice K, Sanchez S, Smith JC, Dees I, Adler J. Cooper WO, et al. Among authors: finlayson ajr. Jt Comm J Qual Patient Saf. 2023 Dec;49(12):671-679. doi: 10.1016/j.jcjq.2023.08.006. Epub 2023 Sep 1. Jt Comm J Qual Patient Saf. 2023. PMID: 37748938 Free article.
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine.
Pather S, Charpentier N, van den Ouweland F, Rizzi R, Finlayson A, Salisch N, Muik A, Lindemann C, Khanim R, Abduljawad S, Smith ER, Gurwith M, Chen RT; Benefit-Risk Assessment of VAccines by TechnolOgy Working Group (BRAVATO; ex-V3SWG). Pather S, et al. Among authors: finlayson a. Vaccine. 2024 Sep 17;42(22):126165. doi: 10.1016/j.vaccine.2024.126165. Epub 2024 Aug 27. Vaccine. 2024. PMID: 39197299 Free article. Review.
Hippocrates on ulcers.
Ali FR, Fox J, Finlayson AE. Ali FR, et al. Among authors: finlayson ae. JAMA Dermatol. 2013 Sep;149(9):1049. doi: 10.1001/jamadermatol.2013.4779. JAMA Dermatol. 2013. PMID: 24048428 No abstract available.
185 results